文献速递消化系统肿瘤

结直肠癌患者血清microRNA-135a-5p的表达水平及其意义

[Expression and significance of serum microRNA-135a-5p level in colorectal cancer].
PubMed 文献 · Zhonghua Zhong Liu Za Zhi · 2016-01-01

该研究随机收集60例原发性结直肠癌患者、40例肠息肉患者和50例健康对照的血清,检测miR135a-5p、CEA和CA199浓度。结直肠癌患者血清miR135a-5p水平显著高于肠息肉患者和健康对照,且与组织学分化和临床分期相关,但与CEA或CA199无相关性。ROC曲线分析显示miR135a-5p对结直肠癌具有较好的诊断效能。

要点

  • 结直肠癌患者血清miR135a-5p水平显著高于肠息肉患者和健康对照(P<0.001)。
  • 血清miR135a-5p水平与结直肠癌组织学分化和临床分期相关(P<0.05)。
  • miR135a-5p诊断结直肠癌的AUC分别为0.832(对比肠息肉)和0.875(对比健康对照)。

核心结论

  • 结直肠癌患者血清miR135a-5p水平显著高于肠息肉患者和健康对照,可能是结直肠癌的重要诊断标志物。

研究设计与样本

  • 随机收集60例原发性结直肠癌患者、40例肠息肉患者和50例健康对照的血清样本,检测miR135a-5p、CEA和CA199浓度。
  • 采用Mann-Whitney U检验分析血清miR135a-5p水平与临床病理参数的关系,Pearson相关检验分析其与CEA或CA199的相关性。
  • 采用ROC曲线和AUC评估miR135a-5p、CEA和CA199的诊断效能。

主要发现

  • 结直肠癌患者血清miR135a-5p水平为2.451(1.107, 4.413),显著高于肠息肉患者的0.946(0.401, 1.942)和健康对照的0.949(0.194, 1.415)(U=351.0和U=313.0,P<0.001)。
  • 结直肠癌患者血清miR135a-5p水平与组织学分化和临床分期均相关(P<0.05)。
  • 结直肠癌患者血清miR135a-5p水平与CEA(r2=0.023,P=0.293)或CA199(r2=0.067,P=0.068)无相关性。
  • 血清miR135a-5p诊断结直肠癌对比肠息肉患者的AUC为0.832(0.730-0.930),对比健康对照的AUC为0.875(0.800-0.950)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To explore the expression level of serum miR135a-5p and its diagnostic value in colorectal cancer (CRC). Methods: Serum samples were randomly collected from 60 primary CRC patients, 40 patients with intestinal polyps and 50 healthy controls, and the serum concentrations of miR135a-5p, CEA and CA199 were detected. The relationships between serum miR135a-5p level and clinicopathological parameters were analyzed by Mann-Whitney U test. The correlation of serum miR135a-5p level and serum concentrations of CEA or CA199 was analyzed by Pearson's correlation test.Receiver operating characteristic (ROC) curves and area under the curve (AUC) were used to evaluate the diagnostic efficacy of miR135a-5p, CEA and CA199 as diagnostic indicators. Results: The serum level of miR135a-5p in CRC patient was 2.451 (1.107, 4.413), significantly higher than 0.946 (0.401, 1.942) in the patients with intestinal polyps and 0.949 (0.194, 1.415) in the healthy controls (U = 351.0 and U = 313.0, respectively, P<0.001). The serum level of miR135a-5p in CRC patients was associated with both histological differentiation and clinical stage (P<0.05 for both), however, not correlated with the serum concentration of CEA (r2 = 0.023, P = 0.293) or CA199 (r2 = 0.067, P = 0.068). The AUC of serum miR135a-5p level in CRC patients was 0.832 (0.730-0.930) when compared to the patients with intestinal polyps and was 0.875 (0.800-0.950) when compared with the healthy controls. Conclusions: The serum level of miR135a-5p in CRC patients is significantly higher than that in patients with intestinal polyps and healthy controls, and might be an important diagnostic marker of CRC.

来源:Zhonghua Zhong Liu Za Zhi,查看原文。版权归原作者所有。

引用

  1. Wang QJ, Zhang HC, Shen XJ, et al. [Expression and significance of serum microRNA-135a-5p level in colorectal cancer]. Zhonghua Zhong Liu Za Zhi. 2016. PMID: 27998467. doi:10.3760/cma.j.issn.0253-3766.2016.12.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。